To Spread or Not to Spread SARS-CoV-2—Is That the Question? | Infectious Diseases | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Views 24,837
Citations 0
Editorial
January 22, 2021

To Spread or Not to Spread SARS-CoV-2—Is That the Question?

Author Affiliations
  • 1Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado, Aurora
  • 2Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora
JAMA Pediatr. Published online January 22, 2021. doi:10.1001/jamapediatrics.2021.0006

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has upended society in many ways. The tragic and rising number of deaths we continue to see throughout the world, the overloaded hospitals, the devastated economies1—all of these appropriately garner daily front-page headlines. However, the impact of this pandemic on children may ultimately prove to have the most lasting effect. Because of concerns about the potential for driving transmission of the virus, with a few exceptions, schools in many parts of the world have been mostly closed to in-person learning since roughly March 2020.2 We have already seen short-term consequences of these closures, and the potential longer-term consequences of a missed year (or more) of learning are dire.3 Nine months into this pandemic, the question of what role children play in transmission of the virus has not been fully answered, with conflicting data, particularly from early in the pandemic, creating a confusing picture.4,5 Without a clearer picture, many schools remain either fully or partially closed to in-person learning because of concerns of both passing the virus to teachers and staff and of bringing it home from schools to their families.

Tönshoff et al6 take us one step closer to a better understanding of the role that children play in the transmission of SARS-CoV-2. In their article, the authors sought to describe the rate of SARS-CoV-2 infections and the seroprevalence of SARS-CoV-2 antibodies in children aged 1 to 10 years compared with a corresponding parent in a population-based sample in southwest Germany. The study enrolled 2482 children aged 1 to 10 years and 2482 corresponding parents from April to May 2020. They tested for the presence of SARS-CoV-2 using reverse transcriptase–polymerase chain reaction of nasopharyngeal swabs and for SARS-CoV-2 IgG antibodies in serum using enzyme-linked immunosorbent assay and immunofluorescence, with discordant results clarified using alternative methods. In the study period, only 2 participants (0.4%), a parent and child in the same family, tested positive for SARS-CoV-2 by polymerase chain reaction. Overall, the estimated seroprevalence was low, with significant differences between parents (1.8%; 95% CI, 1.2-2.4) and children (0.6%; 95% CI, 0.3-1.0). Among the 56 families with at least 1 seropositive child or parent, seropositive parents living with seronegative children were 4.3-fold (95% CI, 1.19-15.52) more common than seropositive children living with seronegative adults. Tönshoff et al6 also attempted to answer certain other questions, such as whether there were differences by age (child aged 1 to 5 years vs 6 to 10 years; no significant differences) and whether childcare attendance influenced seropositivity. Although numbers were fairly small for the childcare attendance outcome, children who attended childcare actually had lower seroprevalence than those who did not (0.5% for children in childcare vs 1.0% for children not in childcare). The authors concluded that children were unlikely to be driving transmission during the pandemic and that mass testing as demonstrated in the study offers a basis for rational political decision-making during a pandemic.

Why does this matter? It has been well-known since early in the pandemic that coronavirus disease 2019 (COVID-19) is a milder disease in children compared with adults, particularly older adults. While it is not completely benign in children, rates of hospitalization and death are far lower in children than adults.7,8 It has also been recognized that children account for a smaller proportion of cases than would be expected based on the size of the childhood population.9 A question that has confounded epidemiologists is whether this simply represents lower rates of testing in children—more severe cases are more likely to get tested—or if they are truly less likely to both acquire infection and spread infection. One way to answer this question, at least in part, is to look at seroprevalence: is there evidence of prior infection? In what Tönshoff et al6 describe as the largest seroprevalence study among children to date, by examining parent-child dyads within the same household, this study suggests that children were both less likely to acquire infection when it was in the household and less likely to spread it in the household when they were infected.

There are several limitations to this study, some of which Tönshoff et al6 acknowledge and some they do not. An important limitation that the authors acknowledge is that this study was performed during a period of lockdown, and children may have been less likely to be exposed than their parents, thus partially explaining the findings. However, the lack of increased prevalence in children in childcare somewhat rebuts this limitation and is consistent with other studies showing relatively low transmission in childcare settings.10,11 The authors also state as a limitation that they are unable to draw conclusions about the infectivity of a child infected with SARS-CoV-2, a limitation that I think is overstated; the fact that there were far fewer adults who were seropositive when a child was seropositive than the converse is at least suggestive of decreased infectivity. Finally, an unacknowledged limitation was that the authors used seropositivity as a marker for prior infection rather than doing a longer prospective polymerase chain reaction–based study to fully ascertain all of the acute infections. While the authors made a strong argument that they used very sensitive and specific methods for ascertaining seroprevalence, one might hypothesize that children do not acquire antibodies at detectable levels after a SARS-CoV-2 infection as frequently as adults and therefore may become infected and spread the virus without developing detectable antibodies, although this seems unlikely.12

Throughout this pandemic, many of us in the field of pediatric infectious diseases have been asked some version of the question, “Can children spread COVID-19?” As if somehow anything in medicine is binary. When a question begins with “can,” the answer is almost always yes. Unfortunately, in too many parts of the world, the decisions to open or not open schools and childcare facilities have stopped there, ignoring the nuance necessary to understand the question. We know far more now about both transmission dynamics and mitigation measures than we did in March 2020 when most schools shut down. The preponderance of evidence now shows that children 10 years and younger, as in the study by Tönshoff et al,6 are both less likely to acquire SARS-CoV-2 infection13,14 and less likely to transmit it to others.15 Proper mitigation measures can reduce that risk even further.16 Therefore, the question we should be asking now is not do or do not children spread SARS-CoV-2; rather, we ought to be asking what we should do with the knowledge we have accumulated since the pandemic began regarding acquisition and transmission of SARS-CoV-2 in children. With this large seroprevalence study6 demonstrating yet again what we have suspected for several months, the answer to that question could not be clearer: we must prioritize the reopening of childcare facilities and elementary schools to full time, in-person learning without exception.

Back to top
Article Information

Corresponding Author: Sean T. O’Leary, MD, MPH, Department of Pediatrics, University of Colorado Anschutz Medical Campus, 13199 E Montview Blvd, Ste 300, Aurora, CO 80045 (sean.oleary@cuanschutz.edu).

Published Online: January 22, 2021. doi:10.1001/jamapediatrics.2021.0006

Conflict of Interest Disclosures: None reported.

References
1.
Fineberg  HV.  The toll of COVID-19.   JAMA. 2020;324(15):1502-1503. doi:10.1001/jama.2020.20019PubMedGoogle ScholarCrossref
2.
Masonbrink  AR, Hurley  E.  Advocating for children during the COVID-19 school closures.   Pediatrics. 2020;146(3):e20201440. doi:10.1542/peds.2020-1440PubMedGoogle Scholar
3.
Patrick  SW, Henkhaus  LE, Zickafoose  JS,  et al.  Well-being of parents and children during the COVID-19 pandemic: a national survey.   Pediatrics. 2020;146(4):e2020016824. doi:10.1542/peds.2020-016824PubMedGoogle Scholar
4.
Bi  Q, Wu  Y, Mei  S,  et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.   Lancet Infect Dis. 2020;20(8):911-919. doi:10.1016/S1473-3099(20)30287-5PubMedGoogle ScholarCrossref
5.
Gudbjartsson  DF, Helgason  A, Jonsson  H,  et al.  Spread of SARS-CoV-2 in the Icelandic population.   N Engl J Med. 2020;382(24):2302-2315. doi:10.1056/NEJMoa2006100PubMedGoogle ScholarCrossref
6.
Tönshoff  B, Müller  B, Elling  R,  et al.  Prevalence of SARS-CoV-2 infection in children and their parents in southwest Germany.   JAMA Pediatr. Published online January 22, 2021. doi:10.1001/jamapediatrics.2021.0001Google Scholar
7.
Gold  JAW, Rossen  LM, Ahmad  FB,  et al.  Race, ethnicity, and age trends in persons who died from COVID-19—United States, May-August 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(42):1517-1521. doi:10.15585/mmwr.mm6942e1PubMedGoogle ScholarCrossref
8.
Kim  L, Whitaker  M, O’Halloran  A,  et al; COVID-NET Surveillance Team.  Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1-July 25, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(32):1081-1088. doi:10.15585/mmwr.mm6932e3PubMedGoogle ScholarCrossref
9.
Bailey  LC, Razzaghi  H, Burrows  EK,  et al.  Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States.   JAMA Pediatr. Published online November 23, 2020. doi:10.1001/jamapediatrics.2020.5052PubMedGoogle Scholar
10.
Hobbs  CV, Martin  LM, Kim  SS,  et al; CDC COVID-19 Response Team.  Factors associated with positive SARS-CoV-2 test results in outpatient health facilities and emergency departments among children and adolescents aged <18 years—Mississippi, September-November 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(50):1925-1929. doi:10.15585/mmwr.mm6950e3PubMedGoogle ScholarCrossref
11.
Link-Gelles  R, DellaGrotta  AL, Molina  C,  et al.  Limited secondary transmission of SARS-CoV-2 in child care programs—Rhode Island, June 1-July 31, 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(34):1170-1172. doi:10.15585/mmwr.mm6934e2PubMedGoogle ScholarCrossref
12.
Weisberg  SP, Connors  TJ, Zhu  Y,  et al.  Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.   Nat Immunol. 2021;22(1):25-31. doi:10.1038/s41590-020-00826-9PubMedGoogle ScholarCrossref
13.
Viner  RM, Mytton  OT, Bonell  C,  et al.  Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis.   JAMA Pediatr. Published online September 25, 2020. doi:10.1001/jamapediatrics.2020.4573PubMedGoogle Scholar
14.
Milani  GP, Bottino  I, Rocchi  A,  et al.  Frequency of children vs adults carrying severe acute respiratory syndrome coronavirus 2 asymptomatically.   JAMA Pediatr. Published online September 14, 2020. doi:10.1001/jamapediatrics.2020.3595PubMedGoogle Scholar
15.
Zhu  Y, Bloxham  CJ, Hulme  KD,  et al.  A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters.   Clin Infect Dis. Published December 6, 2020. doi:10.1093/cid/ciaa1825PubMedGoogle Scholar
16.
Coronado  F, Blough  S, Bergeron  D,  et al.  Implementing mitigation strategies in early care and education settings for prevention of SARS-CoV-2 transmission—eight states, September-October 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(49):1868-1872. doi:10.15585/mmwr.mm6949e3PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Possible question
    Tatiana Bonetti, PhD | Federal University of São Paulo, Brazil
    The knowledge from the study by Tönshoff et al and the comments of this editorial are essential to the discussion aroud reopening of childcare facilities and elementary schools to full time.
    My concern is... the most of studies were done during the lock down periods, children using masks and having very few contact with other children due to the restriction measures. What is the authors opinion about the possibility of the transmission profile change, once children aglomerate in elementary schools for long periods, all week days? considering that children do not keep the restriction measures for long perios of time.
    CONFLICT OF INTEREST: None Reported
    ×